
Akshat Jain MD MPH
Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias
Faculty Clinical Medicine and Pediatrics . Loma Linda University School of Medicine California
Join to View Full Profile
Loma linda Childrens Hospital250 East Caroline StreetLoma Linda, CA 92354
Phone+1 909-651-1910
Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Akshat Jain is a pediatric hematologist and oncologist based in Loma Linda, CA. He specializes in various pediatric hematology subspecialties, including anemia, coagulation disorders, hematologic oncology, and platelet disorders.
Accomplished physician-scientist and clinical trial leader specializing in pediatric hematology/oncology, bleeding disorders, and gene therapy. Renowned for spearheading innovative clinical research, directing comprehensive treatment programs, and advancing curative therapies for inherited blood disorders. Recognized nationally and internationally for leadership in clinical trials, translational research, and policy development to improve outcomes for children and adults with hematologic diseases.
Key Strengths:
- Clinical Trials Leadership: Loma Linda University Clinical Trials Leader for outstanding contributions to the design, execution, and oversight of multicenter clinical trials in bleeding disorders, hemoglobinopathies, and gene therapy.
- Program Development: Medical Director for Hemophilia Treatment Center and NASCC Certified Comprehensive Sickle Cell Center of Excellence at Loma Linda University, overseeing clinical research operations and patient recruitment for innovative therapies after starting both these programs from scratch.
- Translational Research:Chair of the Experimental Therapeutics Research Task Force, driving bench-to-bedside research and facilitating early-phase clinical trials for novel therapeutics in pediatric hematology/oncology.
Education & Training
- Hofstra UniversityMPh, 2015
- OtherClass of 2005
- Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- CA State Medical License 2016 - 2026
- NY State Medical License 2013 - 2016
- ME State Medical License Active through 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Physician of the Year 2025 Hemophilia Foundation of Southern California, 2025
- International Guest Faculty , Chair UNICEF ,Asia, 2025
- Healing Hands Award Loma Linda University Health, 2025
- Join now to see all
Clinical Trials
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders Start of enrollment: 2020 Sep 30
- Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT) Start of enrollment: 2023 Apr 01
- Prophylaxis Regimen for Hemophilia A Patients Start of enrollment: 2022 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease.Stephanie Howe Guarino, Akshat Jain, Mohan Madisetti, Kenneth Rivlin, Payal C Desai
Blood Advances. 2025-09-23 - Barriers to Care for Adults With Sickle Cell Disease: A Qualitative Descriptive Study.Chanell Grismore, Lisa R Roberts, Zephon D Lister, Akshat Jain, Julio Silvestre
Health Expectations. 2025-06-01 - The Heat Is On: Climate Change Implications for Pregnant Women with Sickle Cell Disease.Rachelle Chanmany Pastor, Lisa Roberts, Akshat Jain, Shan Tamares
Women's Health Reports. 2025-01-01
Journal Articles
- Reproductive health in young people with sickle cell diseaseAkshat Jain, APHA, 10/6/2024
- Oxidant Health in sickle cell diseaseJain A., Pediatric Hematology Oncology Journal, 9/8/2018
- Non Alcoholic Fatty Liver Disease in Kabuki SyndromeJain Akshat, See Mary, Journal of Pediatrics and Neonatal Care, 1/1/2015
- Join now to see all
Abstracts/Posters
- Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of "Late"Alemtuzumab; Akshat Jain, Indira Sahdev, Joel Brochstein, 2015 International society of Bone Marrow Transplantation (ISBMT) Tandem meeting, 1/1/2015
- Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinoapthies in ChildrenAllison A King, Nancy Bunin, Indira Sahdev, Joel A Brochstein, Alistair Abraham, Jacqueline Dioguardi,, Naynesh R. Kamani, Akshat Jain, Eric Hanson, Lisa Murray and Sh..., American Society of Hematology December (ASH), 1/1/2014
- Prevalence of Lead poisoning in children 0-16 yrs. of age in Urban North Western IndiaJain A, New York Epidemiology Forum, 1/1/2014
- Join now to see all
Lectures
- Advances in Global HematologyJoseph B Martin Conference Center at Harvard Medical School - 8/2/2015
- Hofstra School of Health Science & Human ServicesBoston Children's Hospital, Joseph B Martin Conference Center at Harvard Medical School - 1/2/2015
- Emergencies in Pediatric Hematology and OncologyNew York Medical College - 1/1/2015
- Join now to see all
Authored Content
- ASH AwardApril 2024
Press Mentions
- California Center Is First in State to Offer Hympavzi for Hemophilia BFebruary 25th, 2025
- LLUH Becomes First in California to Offer Immunotherapy for Hemophilia B PatientsFebruary 20th, 2025
- Navigating Patient Transitions Following the Withdrawal of OxbrytaNovember 21st, 2024
- Join now to see all
Grant Support
- HRSA-23-112 Sickle Cell Disease and Maternal Health Research Collaborative for Minority-Serving InstitutionsHealth Resources and Services Administration (HRSA)2023–2028
- NASCC Electronic Health Record Pediatric to adult transition GrantNational Association of Sickle Cell Centers2023–2025
- American Thrombosis and Hemostasis Network Data GRANTA.T.H.N.2022–2025
Research History
- Clinical TrialistPhase 1 - Phase 4 Clinical Trials as Principal Investigator including various roles as Global P.I., End Point Adjudication Committee , Steering committee for clinical trials .2017 - 2025
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Industry Relationships
- Advisory, BayerAdvisory board for hemophilia treatment strategies2018 - 2018
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: